Journal
INDIAN JOURNAL OF UROLOGY
Volume 38, Issue 2, Pages 99-109Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/iju.iju_416_21
Keywords
-
Categories
Funding
- Science and Engineering Research Board, Department of Science and Technology, Government of India
- Science and Engineering Research Board
Ask authors/readers for more resources
Nuclear magnetic resonance (NMR) metabolomics is a powerful analytical technique for evaluating biochemicals/metabolites associated with cancer and other diseases. It can aid in the diagnosis and understanding of dysregulated metabolic pathways in prostate cancer by detecting metabolites in biofluids and tissues.
Nuclear magnetic resonance (NMR) metabolomics is a powerful analytical technique and a tool which has unique characteristics and capabilities for the evaluation of a number of biochemicals/metabolites of cancer and other disease processes that are present in biofluids (urine and blood) and tissues. The potential of NMR metabolomics in prostate cancer (PCa) has been explored by researchers and its usefulness has been documented. A large number of metabolites such as citrate, choline, and sarcosine were detected by NMR metabolomics from biofluids and tissues related to PCa and their levels were compared with controls and benign prostatic hyperplasia. The changes in the levels of these metabolites aid in the diagnosis and help to understand the dysregulated metabolic pathways in PCa. We review recent studies on in vitro and ex vivo NMR spectroscopy-based PCa metabolomics and its possible role as a diagnostic tool.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available